TCM
Tekla Capital Management Portfolio holdings
AUM
$2.56B
This Quarter Return
+20.64%
1 Year Return
+18.15%
3 Year Return
+62.34%
5 Year Return
+140.22%
10 Year Return
+499.57%
AUM
$2.64B
AUM Growth
+$2.64B
(+15%)
Cap. Flow
-$3.06M
Cap. Flow
% of AUM
-0.12%
Top 10 Holdings %
Top 10 Hldgs %
38.92%
Holding
218
New
26
Increased
62
Reduced
55
Closed
4
Top Buys
| 1 |
Regeneron Pharmaceuticals
REGN
|
$15.6M |
| 2 |
Johnson & Johnson
JNJ
|
$14.4M |
| 3 |
Cigna
CI
|
$13.4M |
| 4 |
Abbott
ABT
|
$13M |
| 5 |
Milestone Pharmaceuticals
MIST
|
$11.2M |
Top Sells
| 1 |
CELG
Celgene Corp
CELG
|
$146M |
| 2 |
UnitedHealth
UNH
|
$26M |
| 3 |
Humana
HUM
|
$10.7M |
| 4 |
Intuitive Surgical
ISRG
|
$9.93M |
| 5 |
Zoetis
ZTS
|
$7.76M |
Sector Composition
| 1 | Healthcare | 94.16% |
| 2 | Real Estate | 3.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Amgen
AMGN
$155B
| $149M | 5.63% | 617,427 -14,860 | -2% | -$3.58M |
|
|
2
Johnson & Johnson
JNJ
$427B
| $134M | 5.06% | 916,827 +98,600 | +12% | +$14.4M |
|
3
Gilead Sciences
GILD
$140B
| $123M | 4.65% | 1,890,576 +56,594 | +3% | +$3.68M |
|
4
Merck
MRK
$210B
| $110M | 4.17% | 1,211,384 | – | – |
|
5
Vertex Pharmaceuticals
VRTX
$100B
| $108M | 4.09% | 493,789 +6,555 | +1% | +$1.44M |
|
6
Illumina
ILMN
$15.8B
| $90.4M | 3.42% | 272,601 +31,462 | +13% | +$10.4M |
|
7
Biogen
BIIB
$19.4B
| $84.6M | 3.2% | 285,126 +27,187 | +11% | +$8.07M |
|
8
Pfizer
PFE
$141B
| $81.7M | 3.09% | 2,085,348 -28,958 | -1% | -$1.13M |
|
|
9
Regeneron Pharmaceuticals
REGN
$61.5B
| $75.6M | 2.86% | 201,277 +41,619 | +26% | +$15.6M |
|
|
10
UnitedHealth
UNH
$281B
| $73.2M | 2.77% | 248,829 -88,454 | -26% | -$26M |
|
11
Medtronic
MDT
$119B
| $53.4M | 2.02% | 470,812 +71,442 | +18% | +$8.11M |
|
12
Bristol-Myers Squibb
BMY
$96B
| $49.7M | 1.88% | 774,862 +36,818 | +5% | +$2.36M |
|
|
ALXN
13
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $47.1M | 1.78% | 435,814 -18,073 | -4% | -$1.95M |
|
|
14
Abbott
ABT
$231B
| $41M | 1.55% | 471,835 +149,322 | +46% | +$13M |
|
15
Thermo Fisher Scientific
TMO
$186B
| $40.1M | 1.52% | 123,408 +34,098 | +38% | +$11.1M |
|
|
16
Cigna
CI
$80.3B
| $39M | 1.47% | 190,555 +65,560 | +52% | +$13.4M |
|
17
CVS Health
CVS
$92.8B
| $37M | 1.4% | 497,986 -42,300 | -8% | -$3.14M |
|
18
Incyte
INCY
$16.5B
| $33.5M | 1.27% | 383,230 -10,500 | -3% | -$917K |
|
|
SGEN
19
DELISTED
Seagen Inc. Common Stock
SGEN
| $31.6M | 1.2% | 276,766 -13,159 | -5% | -$1.5M |
|
20
Elevance Health
ELV
$71.8B
| $30.8M | 1.17% | 102,032 -19,100 | -16% | -$5.77M |
|
|
AGN
21
DELISTED
Allergan plc
AGN
| $30.5M | 1.15% | 159,581 +14,300 | +10% | +$2.73M |
|
22
AbbVie
ABBV
$372B
| $30.2M | 1.14% | 340,916 -59,100 | -15% | -$5.23M |
|
23
Eli Lilly
LLY
$657B
| $27.6M | 1.04% | 210,181 +53,223 | +34% | +$7M |
|
24
Boston Scientific
BSX
$156B
| $25.5M | 0.97% | 564,345 -605 | -0.1% | -$27.4K |
|
25
Danaher
DHR
$147B
| $25.4M | 0.96% | 165,476 +13,100 | +9% | +$2.01M |
|